eLife

A molecule sensor using a two-part designed guide RNA

Updated

Abstract

enables programmable genome editing in human cells by linking protein-protein interactions to CRISPR-Cas9 functionality.

  • Protein-protein interactions can activate prime editing or base editing when coupled with a functional CRISPR-Cas9 system.
  • The strategy modifies the interaction between the guide RNA components to achieve controllable genome editing.
  • Chemically induced dimerization of protein domains is utilized to trigger genome editing processes.
  • Outputs from RNA sensors may guide specific genome edits, enhancing the precision of synthetic molecular circuits.
  • This approach aims to improve the predictability and functionality of synthetic biology applications within living cells.

Simplified

Key numbers

15%
Editing Efficiency
Observed editing efficiency in human cells using .
2% to 53%
Efficiency Range
Range of editing efficiencies observed across different designs and conditions.

Full Text

What this is

  • Synthetic biology aims to design molecular circuits that process information in living cells.
  • Genome editing, particularly with CRISPR-Cas9, is a key tool for these circuits.
  • This research introduces '', which links protein-protein interactions to CRISPR-based genome editing.
  • The approach enhances control over genome editing by using engineered guide RNAs activated by specific protein interactions.

Essence

  • connects protein-protein interactions to CRISPR genome editing, enhancing precision and control in synthetic biology applications. By engineering dual-component guide RNAs, this strategy allows specific molecular events to trigger targeted genome modifications.

Key takeaways

  • utilizes engineered RNA components to convert protein interactions into genome editing events. This method allows for precise genome modifications based on specific protein-protein interactions, expanding the capabilities of CRISPR technology.
  • The study demonstrates that can achieve up to 15% editing efficiency in human cells when using specific protein interactions to induce the formation of active guide RNA complexes.
  • can be coupled with other editing strategies, such as base editing, showing versatility in its application for various genome editing techniques.

Caveats

  • The efficiency of varies, with observed editing rates ranging from 2% to 53% depending on the design and conditions used. Further optimization is needed to enhance both efficiency and specificity.
  • Current tests have only been conducted in HEK293T cells, limiting the generalizability of the findings to other cell types and contexts.
  • The complexity of combining multiple synthetic modules may degrade the overall efficiency and specificity of genome editing outcomes.

Definitions

  • P3 editing: A strategy linking protein-protein interactions to CRISPR-Cas9 genome editing by engineering dual-component guide RNAs.

Simplified

Funding

Competing interests

JC, WC The University of Washington has filed a patent application based on this work, in which J.C., W.C., and J.S. are listed as inventors (WO2024107927A1), HL, XL No competing interests declared, JS The University of Washington has filed a patent application based on this work, in which J.C., W.C., and J.S. are listed as inventors (WO2024107927A1). J.S. is a scientific advisory board member, consultant, and/or co-founder of Cajal Neuroscience, Guardant Health, Maze Therapeutics, Camp4 Therapeutics, Phase Genomics, Adaptive Biotechnologies, Scale Biosciences, Sixth Street Capital, Pacific Biosciences, and Prime Medicine. The remaining authors declare no competing interests
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free